Oral Cancer Awareness in Egypt

Oral Cancer Awareness Level in Egypt: a Pilot Cross-sectional Study

Oral cancer is a fatal disease with high prevalence and poor survival rate. Most oral cancer cases can be detected by the patients themselves. So, when a patient is aware of oral caner, the patient would realize its signs and symptom and seek early medical care; therefore, improving the prognosis.

To our knowledge, the level of awareness of oral cancer has not been investigated in Egyptian population. Therefore, this study is planned to be a pilot study as a first study in Egypt.

Study Overview

• Status: Not yet recruiting
• Conditions: Oral Cancer
• Intervention / Treatment: Other: Questionnaire

Detailed Description

Cancer of the oral cavity is considered a global health burden. According to GLOBOCAN report of 2012, the incidence of oral cancer in Egypt was 1,687 per 10,000 per annum; while the mortality was 659 per 10,000 per annum. Statistically, the rates are expected to increase as to reach 2,658 per 10,000 incidence and 1,069 per 10,000 mortality by the year 2030.

Fortunately, 85% of head and neck cancers are visible. Therefore, the patient does not always need to visit a specialist for a special test to check for oral cancer. Instead, if the patients have basic knowledge about oral cancer, its signs and symptoms and its risk factors, they can detect the change themselves.

As a first step to reach this amazing goal, the level of awareness of the general population needs to be detected.

To the best of our knowledge, the awareness of oral cancer has not been assessed in the general population of Egypt before. As awareness of oral cancer is mandatory for dental practitioners, our study targets the general population other than those working in the dentistry field.

• Study Type: Observational
• Enrollment (Anticipated): 5000

Contacts and Locations

• Study Contact: Name: Ayat Gamal-AbdelNaser, PhD; Phone Number: +2-01001874257; Email: ayat.gamal@dentistry.cu.edu.eg

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

This cross-sectional study aims to quantify the awareness of Egyptian population to oral cancer. The study will be undertaken in the city of 6th of October in Giza governorate. It is a city of population 368,650 inhabitants.

Description

Inclusion criteria:

• Adult individuals (Age>18 years).

Exclusion criteria:

• Dental students or dental practitioners; as awareness of the disease is an integral part of their profession.
• Oral cancer patients: Individuals who experience currently or previously having oral cancer.
• Individuals with mental or communication disabilities.

Study Plan

How is the study designed?

Design Details

• Observational Models: Ecologic or Community
• Time Perspectives: Cross-Sectional

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort

Intervention / Treatment

Sample of the Egyptian population; Participants of Giza residents. Inclusion criteria: • Adult individuals (Age>18 years). Exclusion criteria: Dental students or dental practitioners; as awareness of the disease is an integral part of their profession.; Oral cancer patients: Individuals who experience currently or previously having oral cancer.; Individuals with mental or communication disabilities.

Other: Questionnaire; The questionnaire includes a section for socio-demographic data, a section to detect their general awareness of oral cancer as a disease, a section about their awareness of its signs and symptoms and lastly, a section about its risk factors and habits.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
Level of awareness to oral cancer	6 months

Collaborators and Investigators

• Sponsor: Ayat Gamal-AbdelNaser
• Collaborators: Ahram Canadian University

Study record dates

Study Major Dates

• Study Start (Anticipated): December 1, 2022
• Primary Completion (Anticipated): January 1, 2023
• Study Completion (Anticipated): July 1, 2023

Study Registration Dates

• First Submitted: October 25, 2022
• First Submitted That Met QC Criteria: October 27, 2022
• First Posted (Actual): November 3, 2022

Study Record Updates

• Last Update Posted (Actual): November 3, 2022
• Last Update Submitted That Met QC Criteria: October 27, 2022
• Last Verified: October 1, 2022

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Neoplasms; Neoplasms by Site; Head and Neck Neoplasms; Stomatognathic Diseases; Mouth Diseases; Lip Diseases; Mouth Neoplasms; Lip Neoplasms
• Other Study ID Numbers: ACU-Med1

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: Undecided

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No